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Accepted 17 January 2012AbstractObjective: This study aimed to clarify the usefulness of blastocyst scores and female age as embryo competence markers for embryo transfer in
in vitro fertilization (IVF) cycles.
Materials and Methods: A total of 352 IVF cycles were investigated. The relevance of blastocyst scores and female age to pregnancy outcome
was assessed by logistic regression analysis.
Results: We revealed that, for patients aged < 35 years, the score of the best embryo was the sole factor related to multiple pregnancy, whereas
the score of the best two embryos was the only factor relevant to pregnancy. For patients aged 35e37 years, the score of the best three embryos
was the sole factor correlated to both pregnancy and multiple pregnancy. As for older patients, the correlation between blastocyst morphology
and pregnancy outcome was mainly affected by female age.
Conclusion: The blastocyst score could be used to determine the number of blastocysts transferred to younger patients, but it is less useful for
patients aged > 38 years. For older patients, female age is a better indicator to determine the number of transferred blastocysts.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Blastocyst transfer (BT) is associated with high implanta-
tion and clinical pregnancy rates [1e4]. Allowing cleavage
(Day 2 or Day 3) embryos to develop for 2e3 additional days
facilitates better self-selection of high-quality embryos.
Nonetheless, in order to achieve a higher pregnancy rate of
in vitro fertilization (IVF) cycles, a tendency to transfer mul-
tiple embryos was observed. Due to an increased implantation* Corresponding author. Department of Obstetrics and Gynecology, National
Taiwan University Hospital, Number 8, Chung-Shan South Road, 100, Taipei,
Taiwan.
E-mail address: yangys@ntu.edu.tw (Y.-S. Yang).
1028-4559/$ - see front matter Copyright  2013, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2012.01.038rate in BT cycles, transfer of multiple blastocysts results in an
elevated rate of high-order multiple gestation (HOMG) [1,5].
Multiple gestation has been reported to be associated with
increased rates of preterm birth and perinatal morbidity, and
higher medical care costs [6]. As a result, efforts have been
made to reduce the number of transferred embryos to decrease
multiple pregnancy rates [7e10]. Limiting the number of
high-quality blastocysts transferred is obviously necessary to
avoid multiple gestation. However, in areas or countries where
the cost of IVF is not covered by health insurance, maximizing
the rate of pregnancy while limiting the rate of multiple
gestation remains a major challenge [11].
Major clinical factors related to successful pregnancy by
means of IVF with cleavage-stage embryos include the
following: age of the patient [12], embryo morphology [13],
number of unsuccessful prior attempts, and the number ofcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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adopted an earlier version of guidelines recommended by the
American Society for Reproductive Medicine (ASRM) in
2004 [16] for the number of transferred embryos and groups
the patients according to age (<35 years and 35 years). The
futility of using embryo morphology to predict pregnancy
outcome in IVF cycles for women aged 35 years has been
documented in our previous report [15].
It has been demonstrated that top embryo morphology does
not deteriorate with increased maternal age [17], whereas the
incidence of aneuploidy has been reported to increase with
maternal age [18]. Furthermore, aneuploidy occurs more
frequently in embryos with good morphology and develop-
ment rate than in poorly developed embryos at the cleavage
stage [18]. Thus, the weak connection between embryo
morphology and pregnancy outcome in IVF with cleavage-
stage embryos for women aged 35 years might be attrib-
uted to a high aneuploidy rate. A lower aneuploidy rate has
been reported among blastocysts-stage compared to cleavage-
stage embryos for women aged 36 years [19,20]. Therefore,
BT may be a valuable method to eliminate the effect of female
age on IVF programs.
Blastocyst quality is associated with the success of the BT
program in IVF cycles [21]. In addition, adequate selection of
transferred blastocysts has been proved to improve pregnancy
outcome [22]. As a result, an increased number of IVF pro-
grams have gradually shifted from cleavage-stage embryo
transfer to BT to improve the outcome of IVF cycles. Under
such circumstances, we urge establishing or refining our in-
dividual algorithms to determine better the number of trans-
ferred blastocysts for IVF patients.
The aim of the present study was to develop an algorithm
for BT by retrospectively analyzing the relationships among
blastocyst quality, chronological age, and pregnancy outcome.
Through this analysis, we aimed to ascertain information that
could potentially be used for patient counseling and further
decrease the number of transferred embryos for the BT pro-
gram. In addition, we also attempted to elucidate whether
blastocyst quality, which featured a lower rate of aneuploidy,
could subdue the negative influence of age on IVF outcome.
Materials and methodsStudy participantsThis was a retrospective study of IVF outcomes performed
by reviewing the medical records of patients undergoing IVF
treatment at the National Taiwan University Hospital from
January 2007 to December 2008. Only the first or second
stimulated cycles of the patients were included for analysis. If
both the first and second cycles were performed during the
study period, only the first cycle was included for analysis.
Cycles for oocyte donation or preimplantation genetic diag-
nosis were excluded from analysis. Cycles with one blas-
tocyst available for transfer after in vitro culture for 120 hours
were included. Consequently, a total of 352 BT procedures
met the inclusion criteria and were analyzed in this study.If only one blastocyst was available for transfer subsequent
to in vitro culture, that one blastocyst would be transferred
back into the patients, and this situation was compatible with
the so-called compulsory single embryo transfer (SET; n ¼ 8).
Except for those situations, a total of 344 IVF/intra-
cytoplasmic sperm injection (ICSI) cycles had  two blasto-
cysts available for transfer. Afterwards, all those cycles were
recruited for logistic regression analysis, which was performed
to determine the clinical factors predictive of pregnancy and
multiple pregnancy.
Institutional Review Board approval was not required
because the IVF unit at our hospital is licensed and regulated
by the Human and Fertilization Authority (Bureau of Health
Promotion, Department of Health, Taiwan). There were no
interventions other than those involved in standard IVF
treatment. Furthermore, the principles outlined in the Decla-
ration of Helsinki were followed in the present study.Ovarian stimulation protocols and in vitro embryo
cultureStimulation cycles utilizing the long and short protocols for
gonadotropin- releasing hormone (GnRH) agonist and multi-
ple dose protocol for GnRH antagonist were recruited in the
present study. The formal long and short protocol for
controlled ovarian stimulation has been described previously
[15]. Briefly, the stimulation procedure commenced with the
administration of buserelin (Supromon; Hoechst, Frankfurt,
Germany) combined with recombinant follicle-stimulating
hormone (rFSH; 200e400 IU/day).
The multidose protocol for GnRH antagonist was per-
formed as previously described [23]. Briefly, the stimulation
process commenced with the administration of rFSH (Gonal-F;
Serono, Anbunne, Switzerland) (200 IU/day) for 4 days.
Cetrorelix (0.25 mg, Cetrotide; Serono, Anbunne, Switzerland)
was administered on Day 5 of gonadotropin stimulation.
When two leading follicles ( 18 mm in diameter) appeared
to be present, rFSH treatment was ceased, and 250 mg human
chorionic gonadotropin (hCG, Ovidrel; Serono) was adminis-
tered. Transvaginal oocyte retrieval was performed under ul-
trasound guidance 34 hours after hCG administration.
After oocyte collection and IVF/ICSI, all embryos were
cultured randomly in one of the two sequential media designed
to facilitate blastocyst development. The first system was G
series (G1 and G2; Vitrolife, Kungsbacka, Sweden), and the
second was Quinns Advantage Cleavage and Blastocyst me-
dium (QAC and QAB; SAGE In-Vitro Fertilization, Inc.,
Trumbull, CT, USA). Subsequent to morphological grading by
the same technician, embryo transfer was performed 120 hours
after oocyte retrieval.
Serum hCG levels were checked 12 days after ET. A level
> 50 IU/L was viewed as an indication of pregnancy. Ultra-
sound examination was preformed 3 weeks later in order to
assess fetal heart activity in intrauterine gestational sacs.
Multiple pregnancy was identified by the observation of ac-
tivity of more than one fetal heart. A living child 1 week after
delivery was defined as a live birth [24].
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posed by Gardner and colleagues [25], that is, Grade 1: early
blastocyst, wherein the blastocele is less than half the vol-
ume of the embryo; Grade 2: blastocyst, wherein the blas-
tocele is greater than or equal to half of the volume of the
embryo; Grade 3: full blastocyst, wherein the blastocele
completely fills the embryo; Grade 4: expanded blastocyst,
wherein the blastocele volume is larger than that of the early
embryo and the zona pellucida is thinning; Grade 5: hatching
blastocyst, which the trophectoderm has started to herniate
through the zona pellucida; and Grade 6: hatched blastocyst,
in which the blastocyst has completely escaped from the
zona pellucida.
The development of the inner cell mass (ICM) and tro-
phectoderm was also assessed. The ICM grading was as fol-
lows: A: many cells that are tightly packed; B: several cells
that are loosely grouped; or C: very few cells. The tro-
phectoderm grading was as follows: A: many cells forming a
tightly knit epithelium; B: a few cells; or C: very few cells
forming a loose epithelium. The blastocyst grading was
transformed into a blastocyst score according to the method
described by Rehman et al [26]. The scoring system recoded
the alphabetical grades as numerical form in the simplest
possible manner, that is, A ¼ 3, B ¼ 2, and C ¼ 1. To combine
these three values to obtain a single summary score, multi-
plicative combinations of the three components of blastocyst
grading were utilized [26].
In the current study, the Top1 score was equal to the
blastocyst scoring of the best blastocyst in transferred em-
bryos. The Top2 and Top3 scores were equal to the summation
of the scoring of the best two and three blastocysts in trans-
ferred embryos, respectively. The cumulative embryo score
was equal to the summation of the scoring of all transferred
blastocysts.Statistical analysisThe various biological parameters germane to IVF/ICSI
cycles were compared by Student t test, Fisher’s exact test, c2
test, one-way analysis of variance (ANOVA), or Krus-
kaleWallis test according to various conditions. All analyses
were performed using SPSS version 14.0 (SPSS Inc., Chicago,
IL, USA). When a significant change was detected by
ANOVA, the Bonferroni test was used for subsequent post hoc
multiple comparisons. The differences were considered to be
statistically significant when p was <0.05.
Receiver operating characteristic (ROC) curve analysis was
used to estimate the predictive power of the measured vari-
ables. The relative capability of embryo scoring systems to
predict the IVF outcome was compared by calculating the area
under the ROC curve (AUC) and 95% confidence interval
(CI). MedCalc software version 9.3 was used to compare the
areas under the two ROC curves (MedCalc, Broekstraat,
Belgium). Logistic regression analysis was performed to
assess the independent effects of individual variables.Results
The clinical parameters regarding the outcomes of IVF
procedures for different age groups are summarized in Table 1.
Patients in the younger age group revealed significantly higher
rates of pregnancy and implantation, despite a significantly
lower number of embryos being transferred in the youngest
age group. Nevertheless, the highest rates of multiple preg-
nancies occurred in the group of women aged <35 years. In
this analysis, we suggested three types of embryo morphology
designation: the summation of the score of the best one, two,
and three embryos (Top1, Top2, and Top3, respectively). The
Top1, Top2, and Top3 scores were not significantly different
among the age groups (Table 1).
Patients were grouped on the basis of age (< 35 years vs.
35  age < 38 years vs.  38 years) and ROC AUC com-
parisons were performed to determine the factors (embryo
morphology and patient age) predictive of pregnancy outcome.
As shown in Table 2, Top3 scores were more intimately
correlated with pregnancy than Top1 and Top2 scores in all
groups, except  38 years group. Interestingly, it was only in
the total cohort that age significantly correlated with preg-
nancy (95% CI of ROC AUC did not include 0.5).
Conditional logistic regression analysis was performed to
determine the independence of the following variables: patient
age, baseline FSH levels, number of embryos transferred, and
embryo morphology (Top1, Top2, Top3, and cumulative em-
bryo score scores). These results are summarized in Table 3.
Namely, Top2 score was the sole determinant of pregnancy and
Top1 score was the decisive factor of multiple pregnancy in the
group < 35 years. Furthermore, embryo morphology (Top3
score) was the sole determinant of pregnancy and multiple
pregnancy in the group 35  age < 38 years. Comparatively
speaking, age was a more important determinant of pregnancy
than embryo morphology in the  38 years group.
Of eight patients who received compulsory SET, pregnancy
occurred in only one (1/8; 12.5%) with a 3AA (The 3AA
represents the morphology scoring of blastocysts according
the paragraph for blastocyst scoring system in the section of
Materials and Methods. The “3” means grade 3, the following
“AA” means that inner cell mass is grade A and the tro-
phectoderm is grade A) blastocyst (Top1 ¼ 27). A comparison
of outcomes between patients aged < 35 years receiving two
(n ¼ 51) versus three (n ¼ 93) versus four (n ¼ 43) embryos is
shown in Fig. 1. No significant differences in pregnancy rate
were found among groups receiving various numbers of em-
bryos. However, a significantly lower Top1 score ( p ¼ 0.038),
multiple pregnancy rate (9/24 vs. 21/60 vs. 2/24, p ¼ 0.034)
and implantation rate (51/102 vs. 92/279 vs. 26/172,
p < 0.001) was shown in patients who received four embryos.
The logistic regression models predicting pregnancy and
multiple pregnancy for patients aged < 35 years are shown in
Fig. 2. If Top1 ¼ 27 (3AA) or 12 (3BB or 2AB) (The 3BB and
2AB also represent the morphology scoring of blastocysts
according the paragraph for blastocyst scoring system in the
section of Materials and Methods. The first arabic number
represents blastocele volume, the following two uppercase
Table 1
Outcome of different age groups participating in controlled ovarian stimulation and IVF/ICSI.
Group
Age < 35 y
A (n ¼ 187)
35  Age < 38 y
B (n ¼ 93)
38  Age < 40 y
C (n ¼ 29)
Age  40 y
D (n ¼ 35)
Age (y)a 31.1  2.4 35.9  0.8 38.5  0.5 41.3  2.1
Baseline FSH (IU/L) 6.5  2.4 6.7  2.8 7.5  2.4 6.6  2.3
Short GnRH agonist protocol 95/187 (50.8) 40/93 (43.0) 22/29 (75.9) 22/35 (62.9)
Long GnRH agonist protocol 43/187 (23.0) 27/93 (29.0) 3/29 (10.3) 6/35 (17.1)
GnRH antagonist protocol 49/187 (26.2) 26/93 (28.0) 4/29 (13.8) 7/35 (20.0)
Estradiol on the day of hCG (pg/mL) 3980  2381 3493  2230 3166  1735 3610  1948
Number of retrieved oocytesb 18.4  7.8 16.2  7.5 13.9  5.8 16.0  6.9
ICSI (%) 113/187 (60.4) 55/93 (59.1) 17/29 (58.6) 21/35 (60.0)
Number of transferred embryosc 2.9  0.7 3.3  1.0 3.3  0.7 3.8  0.7
Number of cryopreserved embryosd 6.8  6.4 5.1  5.5 3.6  4.2 4.0  3.9
Score of the best blastocyst 10.8  8.5 9.0  8.1 8.1  7.8 10.2  10.5
Score of the best two blastocysts 17.2  13.7 13.8  11.9 12.9  12.2 15.5  13.6
Score of the best three blastocysts 20.4  18.4 14.9  1.4 16.9  15.6 18.7  15.4
Implantation rate (%)e 158/542 (29.2) 72/307 (23.5) 17/96 (17.7) 16/133 (12.0)
Pregnancy rate (%)f 106/187 (56.7) 47/93 (50.5) 11/29 (37.9) 12/35 (34.3)
Multiple pregnancy rate (%)g 32/187 (17.1) 15/93 (16.1) 4/29 (13.8) 4/35 (11.4)
Live birth rate (%)h 71/187 (38.0) 37/93 (40.0) 6/29 (20.7) 5/35 (14.3)
Data are presented as mean  standard deviation or percentage.
FSH ¼ follicle-stimulating hormone; GnRH ¼ gonadotropin- releasing hormone; hCG ¼ human chorionic gonadotropin; ICSI ¼ intracytoplasmic sperm injection;
IVF ¼ in vitro fertilization.
a p < 0.001; b p ¼ 0.005; c p < 0.001; d p ¼ 0.015 by one-way analysis of variance (ANOVA) test; e p < 0.001; f p < 0.001; g p ¼ 0.027; h p ¼ 0.012 by
c2 test.
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grade, respectively) and two embryos were transferred, the
probability of multiple pregnancy was 47.7% or 39.1%,
respectively.
For patients aged 35e37 years, the estimated rates of
pregnancy and multiple pregnancy are demonstrated in Fig. 3.
If Top3 ¼ 27, the estimated rates of pregnancy and multiple
pregnancy were 40.4% and 20.2%, respectively.
Discussion
In this retrospective analysis, the probabilities of pregnancy
and multiple gestation were calculated with reference to fe-
male age and blastocyst morphology scores. By recoding
Gardner and colleagues grading system for blastocyst
morphology into a cumulative scoring system [26], we were
enabled to determine the probability of pregnancy and multi-
ple gestation in IVF/ICSI cycles. However, for women aged >
38 years, it was female age that was the major factor for
pregnancy outcome in IVF/ICSI cycle.
The assessment of blastocyst morphology before ET is
effective to achieve a high pregnancy rate. Balaban et al haveTable 2
Comparison of areas under the ROC curves of pregnancy outcome for IVF cycles
Predictive factors with Age < 35 y
(n ¼ 187)
35
(n ¼
Score of the best blastocyst (Top1) 0.626 (0.552e0.696)a 0.5
Score of the best two blastocysts (Top2) 0.643 (0.570e0.712)b 0.5
Score of the best three blastocysts (Top3) 0.658 (0.585e0.725)a,b 0.5
Age 0.565 (0.491e0.638) 0.5
Data are presented as 95% confidence intervals (CIs).
IVF ¼ in vitro fertilization; ROC ¼ receiver operating characteristic.
a p ¼ 0.019; b p ¼ 0.025; c p ¼ 0.034; d p ¼ 0.003; e p ¼ 0.018; f p ¼ 0.023;reported that >40% of pregnancies in patients with at least one
good blastocyst (Gardner grading > 3AA, i.e., Top1 > 27)
were multiple gestation, even if the mean number of trans-
ferred embryos was as low as 2.3 [22]. By contrast, only one
multiple pregnancy (1/6; 16.7%) occurred and only a low
implantation rate (11.8%) was obtained when all the trans-
ferred blastocysts had grades < 3AA (Top1 < 27) [22]. A high
implantation rate (51.4%) was obtained with the transfer of at
least one good blastocyst [22]. In the present study, 47.7% of
patients aged < 35 years who received at least one good
embryo (Top1 > 27, i.e., Gardner grading > 3AA) resulted in
multiple gestation. Our findings indicated that transfer of
blastocysts with a high Top1 score resulted in a high rate of
multiple gestation, regardless of whether three or two embryos
were transferred for women aged <35 years.
The high pregnancy rate in patients with good prognosis
(56.7% for women aged <35 years) in the current study is
similar to that reported in other studies about women in IVF/
ICSI cycles with good prognosis [1,25]. However, the implan-
tation rate (29.2% for young women) revealed in the current
study is much lower than those previously reported for the BT
program [50.6% for double embryo transfer (DET)] [25]..
 Age < 38 y
93)
Age  38 y
(n ¼ 64)
Total
(n ¼ 344)
03 (0.397e0.608)c,d 0.737 (0.611e0.840) 0.620 (0.566e0.672)f,g
31 (0.424e0.635)c,e 0.722 (0.594e0.827) 0.637 (0.584e0.688)f,h
54 (0.448e0.658)d,e 0.727 (0.600e0.831) 0.649 (0.596e0.700)g,h
37 (0.431e0.641) 0.625 (0.494e0.744) 0.598 (0.544e0.650)
g p ¼ 0.002; h p ¼ 0.004 by pairwise comparison of ROC curves.
Fig. 1. The score of the best blastocyst (Top1), and the rates of pregnancy,
multiple pregnancy, and implantation for patients aged < 35 years receiving
two, three, and four blastocysts (*p ¼ 0.038 by KruskaleWallis test,
**p ¼ 0.034, and ***p < 0.001 by c2 test).
Table 3
Odds ratio for conditional logistic regression model based on the age of women and the score of the best one, two, or three embryos (Top1, Top 2, or Top3).
Group Age < 35 y (n ¼ 187) 35  Age < 38 y (n ¼ 93) Age  38 y (n ¼ 64) Total (n ¼ 344)
For pregnancy
Age d d 0.659 (0.437e0.993) 0.906 (0.844e0.973)
Top2 1.061 (1.021e1.099) d d d
Top3 d 1.033 (1.012e1.054) d 1.034 (1.014e1.054)
For multiple pregnancy
Age d d d d
Top1 1.110 (1.045e1.180) d d d
Top3 d 1.030 (1.009e1.053) d 1.028 (1.007e1.048)
The odds ratios of significant coefficients are shown as 95% confidence intervals (CIs).
The probability ( p) of multiple pregnancy and pregnancy can be calculated through p ¼ eFertility index/(1 þ eFertility index).
(1) Age < 35 y: Fertility index (pregnancy) ¼ e0.438 þ 0.059  Top2.
(2) 35  Age < 38 y: Fertility index (pregnancy) ¼ e1.254 þ 0.032  Top3.
(3) Age  38 y: Fertility index (pregnancy) ¼ 16.201 e 0.418  Age.
(4) Age < 35 y: Fertility index (multiple pregnancy) ¼ e2.926 þ 0.105  Top1.
(5) 35  Age < 38 y: Fertility index (multiple pregnancy) ¼ e2.185 þ 0.030  Top3.
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women aged<35 years in the present study was almost equal to
that (50.6%) of DET in IVF cycles with good prognosis [25].
The results suggest that some of the embryos transferred were
probably of low implantation potential or poor quality. The
excess transfer of inferior embryos may be due to the clinicians
and/or the patients being uncomfortable with transferring a
small number of embryos to achieve pregnancy, especially
when the blastocysts were of poor quality.
Elective SET may be the best way to eliminate the risk of
multiple gestation [10]. However, some investigators argue
that DET is an acceptable approach [27]. Either a successful
elective SET or DET program requires optimal patient selec-
tion criteria and an efficient embryo cryopreservation program
[28,29]. Individual centers could establish certain criteria for
embryo and patient selection to decrease the rates of multiple
gestation, while maintaining maximal pregnancy rates. The
current study results were in accordance with the guidelines
proposed by the ASRM in 2009 [30]; namely, for patients aged
<35 years, SET should be performed for cycles with goodFig. 2. Logistic regression model of pregnancy and multiple pregnancy for
women aged < 35 years. Top1 and Top2 denote the score of the best blastocyst
and the best two blastocysts, respectively.
Fig. 3. Logistic regression model of live birth and multiple pregnancy for
women aged 35e38 years. Top3 denotes the cumulative scores of the best
three blastocysts.
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for other cycles. We suggest that only one blastocyst should be
transferred into patients with good quality blastocysts
(Top1 > 27) to decrease the rate of multiple conception for
women aged <35 years.
The age of the patient, baseline serumFSH levels, the number
of embryos transferred, and embryo morphology scores were
included for logistic regression analysis in the present study.
This analysis did reveal that the transfer of more than one good
blastocyst in selected patients (those aged<35 years) increased
the rate of multiple gestation. Furthermore, the transfer of more
than two embryos did not further elevate the pregnancy or live
birth rate after IVF treatment. That is to say, the benefits of
transferring multiple blastocysts, in terms of pregnancy
outcome in young IVF patients, peak at the number of two [8].
The relationship between age and natural fertility is neither
linear nor exponential [31]. It has been suggested that there
exists a biphasic association between patient age and IVF
outcome [32]. According to the ASRM guidelines, patients are
classified as the following ages: <35 years, 35e37 years,
38e40 years, and >40 years [30]. In the present study, we
adopted 35 years and 38 years as the cut-off points and found
that the impact of female age was not significant for women
aged < 38 years. Only embryo morphology was closely
associated with the rates of pregnancy and multiple gestation
for patients aged < 38 years. Female age was a more impor-
tant determinant of pregnancy than embryo morphology for
those aged >38 years. The results of the current study were
similar to our previous report about a Day 3 ET program [15].
There were no differences among age group in Top1, Top2,
or Top3 blastocyst scores. The results are concordant with the
observation in cleavage embryos that embryo morphology of
the top quality does not deteriorate with increased maternal
age [17]. Although extended culture to the blastocyst stage is
associated with a low rate of aneuploidy for women with
advanced maternal age [19,20], we still revealed the lack of
correlation between blastocyst morphology and pregnancyoutcome in IVF/ICSI cycles for women aged >38 years. This
indicates that normal morphology of blastocysts does not
guarantee the status of the chromosome and the subsequent
outcome of IVF cycles for advanced age women.
During the years prior to menopause, oocytes in human
ovaries undergo an accelerated rate of loss until the store of
oocytes is nearly depleted. It has been reported that this
accelerated loss is initiated when the total number of oocytes
reaches w25,000, a number or threshold reached in normal
women at age 37e38 years [33,34]. If elective SET instead of
DETwas performed for women aged 35e37 years, they might
lose a chance of achieving a second conception. For women in
this age group, 1 year of delay for pregnancy results in an
accelerated decreased chance of conception [35]. The neces-
sity to split twin pregnancies into singleton pregnancies by
means of elective SET for such women has been questioned
[35]. Therefore, the risk of twin pregnancy and the benefit of
DET should be carefully considered for women aged 35e37
years. The logistic regression model developed in this study
could provide a counseling tool to determine the number of
transferred embryos.
Rather than embryo morphology, other parameters that
better predict the implantation potential for older patients
should be identified to decrease the number of embryos
transferred. Preimplantation genetic screening (PGS) may be
one of the choices [36]. However, PGS is a laborious and
expensive procedure. The cost-effectiveness of PGS for
advanced age women has to be determined by further inves-
tigation. Such parameters are not easily available, therefore,
the ASRM guidelines stratifying women by age is a good
reference for clinical practice. Our results further provide an
individualized algorithm to determine the number of trans-
ferred blastocysts in our center, and it can be safely said that
the results are in accordance with the ASRM guidelines.
In conclusion, patient age and blastocyst morphology score
are important factors that predict pregnancy and multiple
pregnancy in a BT program. The blastocyst score system can
be relied upon to decrease the number of embryos transferred
in younger women undergoing IVF. Other parameters need to
be researched to determine the implantation potential to lower
the number of transferred embryos in older women. Prior to
the identification of these parameters, we suggest developing
an effective strategy for BT programs making the best use of
women’s age and blastocyst morphology to decrease the rate
of multiple pregnancy, and meanwhile maintain a satisfactory
rate of pregnancy.
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